Total Payments
$1,009
2024 Payments
$354.35
Companies
14
Transactions
52
Medicare Patients
335
Medicare Billing
$30,296
Payment Breakdown by Category
Food & Beverage$1,009 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,009 | 52 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $274.91 | 15 | $0 (2024) |
| Lilly USA, LLC | $258.03 | 14 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $136.13 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $91.37 | 6 | $0 (2024) |
| ABBVIE INC. | $67.85 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $42.83 | 3 | $0 (2024) |
| PFIZER INC. | $30.54 | 2 | $0 (2023) |
| Abbott Laboratories | $20.31 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.06 | 1 | $0 (2024) |
| Amgen Inc. | $16.96 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $354.35 | 14 | Otsuka America Pharmaceutical, Inc. ($115.43) |
| 2023 | $228.15 | 12 | Novo Nordisk Inc ($58.16) |
| 2022 | $201.03 | 12 | Lilly USA, LLC ($69.83) |
| 2021 | $225.20 | 14 | Novo Nordisk Inc ($90.82) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: VACCINE | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Respiratory | ||||||
| 11/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Obesity | ||||||
| 10/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Respiratory | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Inflammation | ||||||
| 05/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $115.43 | General |
| Category: PSYCHIATRY | ||||||
| 04/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Diabetes | ||||||
| 04/15/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
| 02/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Diabetes | ||||||
| 02/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Obesity | ||||||
| 12/08/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Diabetes | ||||||
| 08/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Diabetes | ||||||
| 08/08/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Obesity | ||||||
| 07/29/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 07/26/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: PSYCHIATRY | ||||||
| 04/17/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: VACCINES | ||||||
| 03/10/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Obesity | ||||||
| 02/28/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: VACCINES | ||||||
| 02/24/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Diabetes Care | ||||||
| 02/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 68 | 158 | $28,476 | $8,162 |
| 2022 | 5 | 105 | 235 | $29,717 | $11,673 |
| 2021 | 6 | 116 | 182 | $19,400 | $7,418 |
| 2020 | 2 | 46 | 56 | $10,600 | $3,043 |
Total Patients
335
Total Services
631
Medicare Billing
$30,296
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 83 | $6,640 | $2,939 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 38 | $10,678 | $2,330 | 21.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 20 | $7,520 | $2,069 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 17 | $3,638 | $824.07 | 22.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 20 | 112 | $8,690 | $4,182 | 48.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 51 | $11,771 | $3,637 | 30.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 15 | 15 | $3,300 | $1,599 | 48.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 24 | $3,870 | $1,319 | 34.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 15 | 33 | $2,086 | $936.25 | 44.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 58 | $12,080 | $4,230 | 35.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 11 | 57 | $2,850 | $1,470 | 51.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 25 | $3,780 | $1,352 | 35.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 12 | $300.00 | $195.12 | 65.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 15 | 15 | $225.00 | $93.45 | 41.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 15 | 15 | $165.00 | $77.70 | 47.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 32 | 40 | $8,200 | $2,240 | 27.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 16 | $2,400 | $803.06 | 33.5% |
About Michelle Macdonna, CRNP
Michelle Macdonna, CRNP is a Adult Health healthcare provider based in Benson, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2011. The National Provider Identifier (NPI) number assigned to this provider is 1063781052.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michelle Macdonna, CRNP has received a total of $1,009 in payments from pharmaceutical and medical device companies, with $354.35 received in 2024. These payments were reported across 52 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,009).
As a Medicare-enrolled provider, Macdonna has provided services to 335 Medicare beneficiaries, totaling 631 services with total Medicare billing of $30,296. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Health
- Location Benson, NC
- Active Since 12/20/2011
- Last Updated 07/16/2013
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1063781052
Products in Payments
- MOUNJARO (Drug) $147.10
- REXULTI (Drug) $136.13
- TRULICITY (Drug) $93.93
- Rybelsus (Drug) $89.15
- Ozempic (Drug) $77.02
- Wegovy (Drug) $71.82
- VRAYLAR (Drug) $46.98
- FARXIGA (Drug) $42.74
- JARDIANCE (Drug) $35.06
- AIRSUPRA (Drug) $32.44
- BELSOMRA (Drug) $26.67
- UBRELVY (Drug) $20.87
- FREESTYLE LIBRE 3 (Device) $20.31
- Saxenda (Drug) $18.67
- RYBELSUS (Drug) $18.25
- PREVNAR 20 (Biological) $16.97
- Otezla (Drug) $16.96
- CONTRAVE (Drug) $16.70
- BREZTRI (Drug) $16.19
- GARDASIL (Biological) $16.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.